Impact Of Direct Data Capture On Clinical Trial Timelines

The average duration of clinical cycles across various therapy areas exceeds seven years. To put it differently, it takes more than five years, from the initiation of a Phase I trial to the conclusion of a Phase III trial. This is not a recent development; clinical trial durations have remained stagnant or even extended since the year 2000. These lengthy trial timelines result in delays in delivering necessary treatments to patients and are also a significant financial burden on sponsors.

The clinical research community has the potential to leverage technology in order to shorten these timelines. Tools associated with decentralized clinical trials (DCT), such as direct data capture (DDC), represent just one aspect of the effort to reduce these timelines. Explore a broader strategy for shortening clinical trial timelines that encompasses various elements, ranging from enhancing interoperability to implementing AI-driven technologies.